Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

Share Price is delayed by 15 minutes
Get Live Data
206.00    7.30 (3.67%)
Bid:
206.00
Ask:
206.20
Spread: 0.20 (0.097%)
Market Cap: £1.78b
PFD Live PriceLast checked at - London Stock Exchange

Intraday Premier Foods Share Chart

Directorate Change

14 Mar 2018 13:53

RNS Number : 7373H
Premier Foods plc
14 March 2018
 

 

 

Premier Foods plc ("Premier Foods" or the "Company")

14 March 2018

 

Board Retirement

 

Premier Foods announces that Tsunao Kijima, non-executive director, has advised the Company today that he intends to stand down as a director of Premier Foods on 23 March 2018, following his decision to retire from Nissin Foods Holdings Company Ltd ("Nissin"). Mr Kijima has served on the Board since July 2016 pursuant to the terms of the Relationship Agreement between the Company and Nissin.

 

Board Appointment

 

Following Mr Kijima's retirement, Shinji Honda will be appointed as a non-executive director and as Nissin's representative director pursuant to the Relationship Agreement, with effect from 23 March 2018.

 

Mr Honda is Chief Strategy Officer of Nissin, with responsibility for overseas operations, including Europe. Prior to joining Nissin in January 2018, Mr Honda spent his entire professional career at Takeda Pharmaceutical Company Limited ("Takeda"), a leading Japanese pharmaceutical company. He was named Member of the Board of Takeda in June 2013 and Corporate Strategy Officer in October 2014, having previously spent a significant amount of time overseeing Takeda's international operations where his responsibilities included President and CEO of Takeda North America.

 

Commenting on the changes Keith Hamill, Chairman of Premier Foods, said "I would like to take this opportunity to thank Mr Kijima for his significant contribution to both the Board and the partnership between Premier and Nissin, which has helped to ensure the successful launch of a number of exciting new products to market. We welcome Mr Honda to the Board and look forward to working with him in the future".

 

Mr Honda served as Member of the Board of Takeda Pharmaceutical Company Limited (listed on the first section of the Tokyo Stock Exchange) from June 2013 until June 2017. No further information is required to be disclosed pursuant to LR 9.6.13 R.

For further information please contact:

Andrew McDonald, General Counsel & Company Secretary +44 (0) 1727 815 850

Hannah Collyer, Corporate Affairs Director +44 (0) 1727 815 850

Richard Godden, Director of Investor Relations +44 (0) 1727 815 850

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAXZLFFVXFEBBF
Date   Source Headline
1st Oct 20142:08 pmRNSTotal Voting Rights
30th Sep 20149:01 amRNSNotification of Interim Management Statement
29th Sep 20142:30 pmRNSDirector/PDMR Shareholding
22nd Sep 20142:25 pmRNSApproval of an all employee Share Incentive Plan
19th Sep 20143:49 pmRNSHolding(s) in Company
11th Sep 201411:00 amRNSHolding(s) in Company
1st Sep 201410:10 amRNSTotal Voting Rights
7th Aug 20141:40 pmRNSDirector/PDMR Shareholding
1st Aug 20149:00 amRNSTotal Voting Rights
22nd Jul 20147:00 amRNSHalf Yearly Report
17th Jul 20149:00 amRNSBlock Listing for Premier Sharesave
1st Jul 20144:20 pmRNSTotal Voting Rights
30th Jun 20147:00 amRNSCompletion of Knighton Joint Venture
26th Jun 20146:22 pmRNSDirector/PDMR Shareholding
19th Jun 20143:21 pmRNSDirector/PDMR Shareholding
18th Jun 20147:00 amRNSAnnouncement of JV and Trading Update
9th Jun 20145:05 pmRNSHolding(s) in Company
2nd Jun 20149:57 amRNSTotal Voting Rights
22nd May 20149:00 amRNSDirector/PDMR Shareholding
16th May 20149:49 amRNSDirector/PDMR Shareholding
2nd May 20141:46 pmRNSDirector/PDMR Shareholding
1st May 20143:28 pmRNSDirectorate Change
1st May 201411:09 amRNSTotal Voting Rights
29th Apr 20144:30 pmRNSDirector/PDMR Shareholding
29th Apr 20144:23 pmRNSHolding(s) in Company
29th Apr 20144:01 pmRNSResult of AGM
28th Apr 20142:24 pmRNSCompletion of Joint Venture
28th Apr 201411:19 amRNSHolding(s) in Company
24th Apr 20142:22 pmRNSDirector/PDMR Shareholding
24th Apr 20147:00 amRNSInterim Management Statement
16th Apr 20143:00 pmRNSDirector/PDMR Shareholding
15th Apr 20149:00 amRNSNotification of Interim Management Statement
14th Apr 20142:25 pmRNSReceipt of Proceeds re. Capital Refinancing Plan
11th Apr 201410:22 amRNSHolding(s) in Company
8th Apr 20145:13 pmRNSHolding(s) in Company
8th Apr 201412:58 pmRNSHolding(s) in Company
8th Apr 20149:36 amRNSResult of Rump Placing
8th Apr 20149:00 amRNSTotal Voting Rights
8th Apr 20148:37 amRNSDirector/PDMR Shareholding
8th Apr 20147:00 amRNSResult of Rights Issue
2nd Apr 20143:18 pmRNSDirector/PDMR Shareholding
1st Apr 201411:06 amRNSTotal Voting Rights
1st Apr 201410:00 amRNSBlocklisting Interim Review
31st Mar 20142:29 pmRNSShort Selling Disclosure
31st Mar 20148:55 amRNSHolding(s) in Company
31st Mar 20148:20 amRNSCompetition Approval
27th Mar 20144:00 pmRNSDirector/PDMR Shareholding
26th Mar 20145:04 pmRNSAnnual Financial Report
26th Mar 20143:48 pmRNSHolding(s) in Company
24th Mar 20144:11 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.